-Oncolytics Biotech Announces Publication of Positive REO 024 Study Results for Pelareorep in Combination with Keytruda in Patients with Advanced Pancreatic Adenocarcinoma

Press/Media: Press / Media

PeriodNov 7 2019

Media coverage

1

Media coverage

  • Title-Oncolytics Biotech Announces Publication of Positive REO 024 Study Results for Pelareorep in Combination with Keytruda in Patients with Advanced Pancreatic Adenocarcinoma
    Media name/outletENP Newswire
    CountryUnited Kingdom
    Date11/7/19
    PersonsDevalingam Mahalingam